Search for: "AstraZeneca Inc."
Results 161 - 180
of 340
Sorted by Relevance
|
Sort by Date
23 Jul 2017, 4:00 am
Pharmaceutical Patents: “Promise of the Patent” Doctrine re Utility AstraZeneca Canada Inc. v. [read post]
5 May 2010, 4:46 am
Impax Laboratories Inc. [read post]
27 May 2010, 3:20 am
AstraZeneca Pharmaceuticals LP et al. [read post]
1 Dec 2010, 12:15 am
Abraxis Bioscience, Inc. v. [read post]
12 Oct 2010, 8:56 pm
Highlights this week included: Aricept(Donepezil) –US: Declaratory judgment jurisdiction for subsequent Paragraph IV filers: Teva Pharmaceuticals USA, Inc. v. [read post]
8 Jul 2016, 4:00 am
Astrazeneca Canada Inc., 2012 FC 559 by Justice Hughes and of accounting experts for a copyright counterclaim by Justice de Montigny in Distrimedic Inc. v. [read post]
3 Oct 2009, 9:05 pm
" Astrazeneca AB v. [read post]
29 Jun 2010, 6:01 pm
Sandoz Inc. [read post]
30 Jun 2010, 5:52 am
Sandoz Inc. [read post]
27 Feb 2009, 5:00 am
Teva Parenteral Medicines Inc. et al. [read post]
10 Sep 2012, 7:28 pm
., Glaxo, Inc. v. [read post]
7 Oct 2009, 5:30 pm
AstraZeneca LP v. [read post]
8 Jun 2009, 6:46 am
" As a result, the FDA is now "considering applications for AstraZeneca PLC's Seroquel [quetiapine] and Eli Lilly and Co.'s Zyprexa [olanzapine] to treat bipolar disorder and schizophrenia in children and adolescents, and Pfizer, Inc.'s Geodon [ziprasidone] to treat bipolar disorder in children 10 to 17," comments the report. [read post]
13 Jun 2008, 8:29 am
DISTRICT COURTSOUTHERN DISTRICT OF NEW YORKBusiness LawAstraZeneca Share Manipulation Claims Dismissed On Jurisdiction Grounds, Failure to Plead ScienterIn re AstraZeneca Securities LitigationU.S. [read post]
29 Dec 2009, 9:09 pm
Miller, Vice President of Corporate Business Development, Eli Lilly Reid Leonard, Vice President External Licensing and Business Development, Merck Jules Musling, VP, Johnson & Johnson Carlos Garrido, Finance Director , Head of Strategic Planning and Business Development South America, AstraZeneca Peter Verheyen, VP Business Development, Johnson & Johnson Michael Lytton, EVP Business Development, Biogen Idec Inc Mark Dennish, Vice President, Business Development, Daiichi… [read post]
29 Dec 2009, 9:09 pm
Miller, Vice President of Corporate Business Development, Eli Lilly Reid Leonard, Vice President External Licensing and Business Development, Merck Jules Musling, VP, Johnson & Johnson Carlos Garrido, Finance Director , Head of Strategic Planning and Business Development South America, AstraZeneca Peter Verheyen, VP Business Development, Johnson & Johnson Michael Lytton, EVP Business Development, Biogen Idec Inc Mark Dennish, Vice President, Business Development, Daiichi… [read post]
5 Jul 2017, 11:34 am
Canadian Supreme Court holds promise doctrine "unsound" in AstraZeneca v Apotex Nexium disputeThe AmeriKat Annsley provides a timely and in-depth analysis on the much-awaited decision rendered by the Supreme Court of Canada in the appeal between AstraZeneca Canada v Apotex (2017 SCC 36). [read post]
19 May 2010, 6:15 am
Immutopics, Inc. [read post]
16 Dec 2009, 3:39 am
: Ariad Pharmaceuticals, Inc. v. [read post]
12 Nov 2012, 10:40 am
AstraZeneca Pharmaceutical, Inc., 203 Fed. [read post]
